Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk

Dow Jones

01/19

2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. "We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services," says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

January 18, 2026 18:40 ET (23:40 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2604970907"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604970907\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604970907?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 07:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604970907","market":"nz","top_or_hot":-1,"title":"Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 18, 2026 18:40 ET (23:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-01-19 07:40</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 18, 2026 18:40 ET (23:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COH.AU","symbol_name":"COCHLEAR LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2604970907","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604970907","pubTimestamp":1768779600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COH.AU":"COCHLEAR LTD","BK7007":"医疗保健设备"},"translate_title":"尽管上半年盈利可能低于预期，科利耳仍获得新的牛市——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COH.AU":0.9},"content_text":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 18, 2026 18:40 ET (23:40 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}